A 2023 study conducted on patients with major depressive disorder (MDD), stratified into groups with high and low CRP levels and compared with healthy controls, showed that both MDD groups exhibited significantly higher leptin concentrations than controls. The gene discussed is CRP; the disease is major depressive disorder.